Position
Chief Financial Officer
Company
Ascidian Therapeutics
BostonBiotechnologyHealth CareMedicalTherapeuticsDescription
Ascidian Therapeutics announces the appointment of Daniel Rosan as President while retaining his roles as Chief Financial Officer and Chief Business Officer. This transition is part of a leadership shift as the company progresses through its CEO succession process.
Quick answer
Ascidian Therapeutics Appoints Daniel Rosan as President (July 21, 2026). Ascidian Therapeutics is based in Boston, Massachusetts, United States.
- Who is the new Chief Financial Officer at Ascidian Therapeutics?
- Ascidian Therapeutics named Daniel Rosan Chief Financial Officer, announced July 21, 2026.
- What did Ascidian Therapeutics announce on July 21, 2026?
- Ascidian Therapeutics announces the appointment of Daniel Rosan as President while retaining his roles as Chief Financial Officer and Chief Business Officer. This transition is part of a leadership shift as the company progresses through its CEO succession process.
- What does Ascidian Therapeutics do?
- Ascidian Therapeutics is redefining the treatment of disease by rewriting RNA.
- Where is Ascidian Therapeutics based?
- Ascidian Therapeutics is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Harmony Biosciences (July 23, 2026), Imugene (July 27, 2026), Illuminare Biotechnologies (July 14, 2026) and Aqua Medical (August 4, 2026) also announced leadership changes within 45 days of Ascidian Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Harmony Biosciences Appoints Stephen Mollichella as Interim CFO (July 23, 2026)
- Imugene Limited Announces Resignation of CEO Leslie Chong Effective Immediately (July 27, 2026)
- Illuminare Biotechnologies Appoints Brian Longstreet as Chief Executive Officer (July 14, 2026)
- Aqua Medical Appoints Robert Haggerty as President and Chief Executive Officer (August 4, 2026)
- Immunocine Cancer Center Appoints Vita S. Salsman as Executive Director (July 7, 2026)
- First Ascent Biomedical Appoints Raymond Rodriguez-Torres as President (June 22, 2026)
Who to call at Ascidian Therapeutics, and when
A new leader at Ascidian Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Ascidian Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ascidian Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ascidian Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ascidian Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Ascidian Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.